+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Immunofluorescence Assay - Market Analysis, Trends, and Forecasts

  • ID: 4805504
  • Report
  • October 2019
  • Region: Global
  • 239 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abcam Plc
  • Bio-Rad Laboratories
  • Cell Signaling Technology
  • Danaher Corporation
  • Inova Diagnostics
  • Medipan Gmbh
  • MORE
The Immunofluorescence Assay market worldwide is projected to grow by US$698.9 Million, driven by a compounded growth of 5.5%. Reagents, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1 Billion by the year 2025, Reagents will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$32.2 Million to the region's size and clout in the next 5 to 6 years. Over US$32.7 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Reagents will reach a market size of US$87.6 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 5.3% over the next couple of years and add approximately US$121.1 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • INOVA Diagnostics, Inc.
  • Medipan GmbH
  • MilliporeSigma
  • PerkinElmer, Inc.
  • Sino Biological Inc.
  • Thermo Fisher Scientific, Inc.
  • Vector Laboratories, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abcam Plc
  • Bio-Rad Laboratories
  • Cell Signaling Technology
  • Danaher Corporation
  • Inova Diagnostics
  • Medipan Gmbh
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Immunofluorescence Assay Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Immunofluorescence Assay Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 2: Immunofluorescence Assay Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017

TABLE 3: Immunofluorescence Assay Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Reagents (Product) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 5: Reagents (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 6: Reagents (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Instruments (Product) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 8: Instruments (Product) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017

TABLE 9: Instruments (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Antibodies (Product) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025

TABLE 11: Antibodies (Product) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017

TABLE 12: Antibodies (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Kits (Product) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025

TABLE 14: Kits (Product) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017

TABLE 15: Kits (Product) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Consumables & Accessories (Product) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 17: Consumables & Accessories (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 18: Consumables & Accessories (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Indirect Immunofluorescence (Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025

TABLE 20: Indirect Immunofluorescence (Type) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017

TABLE 21: Indirect Immunofluorescence (Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Direct Immunofluorescence (Type) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025

TABLE 23: Direct Immunofluorescence (Type) Global Historic Demand in US$ Thousand by Region/Country: 2009 to 2017

TABLE 24: Direct Immunofluorescence (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Cancer (Disease) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 26: Cancer (Disease) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 27: Cancer (Disease) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 28: Infectious Diseases (Disease) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 29: Infectious Diseases (Disease) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017

TABLE 30: Infectious Diseases (Disease) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 31: Autoimmune Diseases (Disease) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025

TABLE 32: Autoimmune Diseases (Disease) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017

TABLE 33: Autoimmune Diseases (Disease) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 34: Cardiovascular Diseases (Disease) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025

TABLE 35: Cardiovascular Diseases (Disease) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017

TABLE 36: Cardiovascular Diseases (Disease) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 37: Other Diseases (Disease) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 38: Other Diseases (Disease) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 39: Other Diseases (Disease) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 40: Pharmaceutical & Biotechnology Companies (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025

TABLE 41: Pharmaceutical & Biotechnology Companies (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017

TABLE 42: Pharmaceutical & Biotechnology Companies (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 43: Academic & Research Institutes (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025

TABLE 44: Academic & Research Institutes (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2009-2017

TABLE 45: Academic & Research Institutes (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025

TABLE 46: Hospitals & Diagnostic Centers (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 47: Hospitals & Diagnostic Centers (End-Use) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2009-2017

TABLE 48: Hospitals & Diagnostic Centers (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 49: Contract Research Organizations (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2018-2025

TABLE 50: Contract Research Organizations (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017

TABLE 51: Contract Research Organizations (End-Use) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Immunofluorescence Assay Market Share (in %) by Company: 2019 & 2025

TABLE 52: United States Immunofluorescence Assay Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025

TABLE 53: Immunofluorescence Assay Market in the United States by Product: A Historic Review in US$ Thousand for 2009-2017

TABLE 54: United States Immunofluorescence Assay Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 55: United States Immunofluorescence Assay Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025

TABLE 56: Immunofluorescence Assay Market in the United States by Type: A Historic Review in US$ Thousand for 2009-2017

TABLE 57: United States Immunofluorescence Assay Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 58: United States Immunofluorescence Assay Market Estimates and Projections in US$ Thousand by Disease: 2018 to 2025

TABLE 59: Immunofluorescence Assay Market in the United States by Disease: A Historic Review in US$ Thousand for 2009-2017

TABLE 60: United States Immunofluorescence Assay Market Share Breakdown by Disease: 2009 VS 2019 VS 2025

TABLE 61: United States Immunofluorescence Assay Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025

TABLE 62: Immunofluorescence Assay Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2009-2017

TABLE 63: Immunofluorescence Assay Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025

CANADA

TABLE 64: Canadian Immunofluorescence Assay Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025

TABLE 65: Canadian Immunofluorescence Assay Historic Market Review by Product in US$ Thousand: 2009-2017

TABLE 66: Immunofluorescence Assay Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

TABLE 67: Canadian Immunofluorescence Assay Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025

TABLE 68: Canadian Immunofluorescence Assay Historic Market Review by Type in US$ Thousand: 2009-2017

TABLE 69: Immunofluorescence Assay Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 70: Canadian Immunofluorescence Assay Market Estimates and Forecasts in US$ Thousand by Disease: 2018 to 2025

TABLE 71: Canadian Immunofluorescence Assay Historic Market Review by Disease in US$ Thousand: 2009-2017

TABLE 72: Immunofluorescence Assay Market in Canada: Percentage Share Breakdown of Sales by Disease for 2009, 2019, and 2025

TABLE 73: Canadian Immunofluorescence Assay Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025

TABLE 74: Immunofluorescence Assay Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017

TABLE 75: Canadian Immunofluorescence Assay Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

JAPAN

TABLE 76: Japanese Market for Immunofluorescence Assay: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025

TABLE 77: Immunofluorescence Assay Market in Japan: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017

TABLE 78: Japanese Immunofluorescence Assay Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 79: Japanese Market for Immunofluorescence Assay: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025

TABLE 80: Immunofluorescence Assay Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017

TABLE 81: Japanese Immunofluorescence Assay Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 82: Japanese Market for Immunofluorescence Assay: Annual Sales Estimates and Projections in US$ Thousand by Disease for the Period 2018-2025

TABLE 83: Immunofluorescence Assay Market in Japan: Historic Sales Analysis in US$ Thousand by Disease for the Period 2009-2017

TABLE 84: Japanese Immunofluorescence Assay Market Share Analysis by Disease: 2009 VS 2019 VS 2025

TABLE 85: Japanese Demand Estimates and Forecasts for Immunofluorescence Assay in US$ Thousand by End-Use: 2018 to 2025

TABLE 86: Japanese Immunofluorescence Assay Market in US$ Thousand by End-Use: 2009-2017

TABLE 87: Immunofluorescence Assay Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025

CHINA

TABLE 88: Chinese Immunofluorescence Assay Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025

TABLE 89: Immunofluorescence Assay Historic Market Analysis in China in US$ Thousand by Product: 2009-2017

TABLE 90: Chinese Immunofluorescence Assay Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 91: Chinese Immunofluorescence Assay Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025

TABLE 92: Immunofluorescence Assay Historic Market Analysis in China in US$ Thousand by Type: 2009-2017

TABLE 93: Chinese Immunofluorescence Assay Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 94: Chinese Immunofluorescence Assay Market Growth Prospects in US$ Thousand by Disease for the Period 2018-2025

TABLE 95: Immunofluorescence Assay Historic Market Analysis in China in US$ Thousand by Disease: 2009-2017

TABLE 96: Chinese Immunofluorescence Assay Market by Disease: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 97: Chinese Demand for Immunofluorescence Assay in US$ Thousand by End-Use: 2018 to 2025

TABLE 98: Immunofluorescence Assay Market Review in China in US$ Thousand by End-Use: 2009-2017

TABLE 99: Chinese Immunofluorescence Assay Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025

EUROPE

Market Facts & Figures

European Immunofluorescence Assay Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 100: European Immunofluorescence Assay Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025

TABLE 101: Immunofluorescence Assay Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017

TABLE 102: European Immunofluorescence Assay Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 103: European Immunofluorescence Assay Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025

TABLE 104: Immunofluorescence Assay Market in Europe in US$ Thousand by Product: A Historic Review for the Period 2009-2017

TABLE 105: European Immunofluorescence Assay Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 106: European Immunofluorescence Assay Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025

TABLE 107: Immunofluorescence Assay Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017

TABLE 108: European Immunofluorescence Assay Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 109: European Immunofluorescence Assay Market Estimates and Forecasts in US$ Thousand by Disease: 2018-2025

TABLE 110: Immunofluorescence Assay Market in Europe in US$ Thousand by Disease: A Historic Review for the Period 2009-2017

TABLE 111: European Immunofluorescence Assay Market Share Breakdown by Disease: 2009 VS 2019 VS 2025

TABLE 112: European Immunofluorescence Assay Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025

TABLE 113: Immunofluorescence Assay Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017

TABLE 114: European Immunofluorescence Assay Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

FRANCE

TABLE 115: Immunofluorescence Assay Market in France by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 116: French Immunofluorescence Assay Historic Market Scenario in US$ Thousand by Product: 2009-2017

TABLE 117: French Immunofluorescence Assay Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 118: Immunofluorescence Assay Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 119: French Immunofluorescence Assay Historic Market Scenario in US$ Thousand by Type: 2009-2017

TABLE 120: French Immunofluorescence Assay Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 121: Immunofluorescence Assay Market in France by Disease: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 122: French Immunofluorescence Assay Historic Market Scenario in US$ Thousand by Disease: 2009-2017

TABLE 123: French Immunofluorescence Assay Market Share Analysis by Disease: 2009 VS 2019 VS 2025

TABLE 124: Immunofluorescence Assay Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2018-2025

TABLE 125: French Immunofluorescence Assay Historic Market Review in US$ Thousand by End-Use: 2009-2017

TABLE 126: French Immunofluorescence Assay Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025

GERMANY

TABLE 127: Immunofluorescence Assay Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025

TABLE 128: German Immunofluorescence Assay Historic Market Analysis in US$ Thousand by Product: 2009-2017

TABLE 129: German Immunofluorescence Assay Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 130: Immunofluorescence Assay Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025

TABLE 131: German Immunofluorescence Assay Historic Market Analysis in US$ Thousand by Type: 2009-2017

TABLE 132: German Immunofluorescence Assay Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 133: Immunofluorescence Assay Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Disease for the Period 2018-2025

TABLE 134: German Immunofluorescence Assay Historic Market Analysis in US$ Thousand by Disease: 2009-2017

TABLE 135: German Immunofluorescence Assay Market Share Breakdown by Disease: 2009 VS 2019 VS 2025

TABLE 136: Immunofluorescence Assay Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025

TABLE 137: German Immunofluorescence Assay Market in Retrospect in US$ Thousand by End-Use: 2009-2017

TABLE 138: Immunofluorescence Assay Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025

ITALY

TABLE 139: Italian Immunofluorescence Assay Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025

TABLE 140: Immunofluorescence Assay Historic Market Analysis in Italy in US$ Thousand by Product: 2009-2017

TABLE 141: Italian Immunofluorescence Assay Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 142: Italian Immunofluorescence Assay Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025

TABLE 143: Immunofluorescence Assay Historic Market Analysis in Italy in US$ Thousand by Type: 2009-2017

TABLE 144: Italian Immunofluorescence Assay Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 145: Italian Immunofluorescence Assay Market Growth Prospects in US$ Thousand by Disease for the Period 2018-2025

TABLE 146: Immunofluorescence Assay Historic Market Analysis in Italy in US$ Thousand by Disease: 2009-2017

TABLE 147: Italian Immunofluorescence Assay Market by Disease: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 148: Italian Demand for Immunofluorescence Assay in US$ Thousand by End-Use: 2018 to 2025

TABLE 149: Immunofluorescence Assay Market Review in Italy in US$ Thousand by End-Use: 2009-2017

TABLE 150: Italian Immunofluorescence Assay Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025

UNITED KINGDOM

TABLE 151: United Kingdom Market for Immunofluorescence Assay: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025

TABLE 152: Immunofluorescence Assay Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017

TABLE 153: United Kingdom Immunofluorescence Assay Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 154: United Kingdom Market for Immunofluorescence Assay: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025

TABLE 155: Immunofluorescence Assay Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017

TABLE 156: United Kingdom Immunofluorescence Assay Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 157: United Kingdom Market for Immunofluorescence Assay: Annual Sales Estimates and Projections in US$ Thousand by Disease for the Period 2018-2025

TABLE 158: Immunofluorescence Assay Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Disease for the Period 2009-2017

TABLE 159: United Kingdom Immunofluorescence Assay Market Share Analysis by Disease: 2009 VS 2019 VS 2025

TABLE 160: United Kingdom Demand Estimates and Forecasts for Immunofluorescence Assay in US$ Thousand by End-Use: 2018 to 2025

TABLE 161: United Kingdom Immunofluorescence Assay Market in US$ Thousand by End-Use: 2009-2017

TABLE 162: Immunofluorescence Assay Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 163: Rest of Europe Immunofluorescence Assay Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025

TABLE 164: Immunofluorescence Assay Market in Rest of Europe in US$ Thousand by Product: A Historic Review for the Period 2009-2017

TABLE 165: Rest of Europe Immunofluorescence Assay Market Share Breakdown by Product: 2009 VS 2019 VS 2025

TABLE 166: Rest of Europe Immunofluorescence Assay Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025

TABLE 167: Immunofluorescence Assay Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017

TABLE 168: Rest of Europe Immunofluorescence Assay Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 169: Rest of Europe Immunofluorescence Assay Market Estimates and Forecasts in US$ Thousand by Disease: 2018-2025

TABLE 170: Immunofluorescence Assay Market in Rest of Europe in US$ Thousand by Disease: A Historic Review for the Period 2009-2017

TABLE 171: Rest of Europe Immunofluorescence Assay Market Share Breakdown by Disease: 2009 VS 2019 VS 2025

TABLE 172: Rest of Europe Immunofluorescence Assay Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025

TABLE 173: Immunofluorescence Assay Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017

TABLE 174: Rest of Europe Immunofluorescence Assay Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 175: Immunofluorescence Assay Market in Asia-Pacific by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 176: Asia-Pacific Immunofluorescence Assay Historic Market Scenario in US$ Thousand by Product: 2009-2017

TABLE 177: Asia-Pacific Immunofluorescence Assay Market Share Analysis by Product: 2009 VS 2019 VS 2025

TABLE 178: Immunofluorescence Assay Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 179: Asia-Pacific Immunofluorescence Assay Historic Market Scenario in US$ Thousand by Type: 2009-2017

TABLE 180: Asia-Pacific Immunofluorescence Assay Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 181: Immunofluorescence Assay Market in Asia-Pacific by Disease: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 182: Asia-Pacific Immunofluorescence Assay Historic Market Scenario in US$ Thousand by Disease: 2009-2017

TABLE 183: Asia-Pacific Immunofluorescence Assay Market Share Analysis by Disease: 2009 VS 2019 VS 2025

TABLE 184: Immunofluorescence Assay Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2018-2025

TABLE 185: Asia-Pacific Immunofluorescence Assay Historic Market Review in US$ Thousand by End-Use: 2009-2017

TABLE 186: Asia-Pacific Immunofluorescence Assay Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025

REST OF WORLD

TABLE 187: Rest of World Immunofluorescence Assay Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025

TABLE 188: Rest of World Immunofluorescence Assay Historic Market Review by Product in US$ Thousand: 2009-2017

TABLE 189: Immunofluorescence Assay Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

TABLE 190: Rest of World Immunofluorescence Assay Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025

TABLE 191: Rest of World Immunofluorescence Assay Historic Market Review by Type in US$ Thousand: 2009-2017

TABLE 192: Immunofluorescence Assay Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 193: Rest of World Immunofluorescence Assay Market Estimates and Forecasts in US$ Thousand by Disease: 2018 to 2025

TABLE 194: Rest of World Immunofluorescence Assay Historic Market Review by Disease in US$ Thousand: 2009-2017

TABLE 195: Immunofluorescence Assay Market in Rest of World: Percentage Share Breakdown of Sales by Disease for 2009, 2019, and 2025

TABLE 196: Rest of World Immunofluorescence Assay Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025

TABLE 197: Immunofluorescence Assay Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017

TABLE 198: Rest of World Immunofluorescence Assay Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

IV. COMPETITION

ABCAM PLC

BIO-RAD LABORATORIES

CELL SIGNALING TECHNOLOGY

DANAHER CORPORATION

INOVA DIAGNOSTICS

MEDIPAN GMBH

MILLIPORESIGMA

PERKINELMER

SINO BIOLOGICAL

THERMO FISHER SCIENTIFIC

VECTOR LABORATORIES, INC.

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abcam Plc
  • Bio-Rad Laboratories
  • Cell Signaling Technology
  • Danaher Corporation
  • Inova Diagnostics
  • Medipan Gmbh
  • Milliporesigma
  • Perkinelmer
  • Sino Biological
  • Thermo Fisher Scientific
  • Vector Laboratories, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll